One mode through which immune system latches onto foreign substances is by constructing massive numbers of antibodies. Antibodies hover around the body until they spot the antigen; once attached—they can engage other parts of the immune system to decimate the antigen containing cells.
Soaring incidence of chronic diseases such as cancer, diabetes and autoimmune conditions have acted as catalysts to drug makers to further augment antibody-based products. Consequently, research and development activities concerning antibodies has exponentially propped up in the past few decades. Meanwhile, the U.S. Food and Drug Administration (FDA) has given consent to more than a dozen mAbs to treat certain cancers. In addition, soaring acceptance of protein therapeutics along with ubiquity of epidemic diseases is having a sanguine impact on the sale of antibody-based products. However, one of the underlying problems is the prevalence of alternative therapeutics which does not augur well with the development of antibodies in global scale. Besides, high cost and side effects pertaining to antibodies further act as impediment to the sale of antibodies-based drug.
Currently, North America dominates the global antibodies market in terms of revenue and trend is projected continue in 2017 and beyond. In addition, the market in the region is expected to increase at a moderate CAGR during the forecast period (2017-2022). Presence of leading market players and existence of a well-established healthcare infrastructure is supporting the growth of the market in the region.
As B lymphocytes or B cells are pivotal in the production of antibodies, combined together they offer indispensable function of immunity. Offering a basis for the augmentation of therapeutic antibodies and for vaccine development turns out to be pivotal incentive for measuring antibody function.
Antibodies Market: Overview
The report moots a comprehensive analysis on the market for antibodies for the assessment period 2018-2026. The report also delves into the dynamics surrounding the antibodies which significantly influence the growth of the Antibodies Market.
Furthermore, the report elucidates the segregation of the market which is anticipated to provide readers with an actionable insights which will aid them in taking proper decision based on segments historical and future growth estimates.
Browse Full Report with ToC Here:
https://www.factmr.com/report/194/antibodies-market
The report focuses on cost structure and supply chain to provide a holistic view of the antibodies market. The report provides a coherent assessment through average pricing analysis. The report also includes regional and country-wise assessment.
A qualitative and quantitative information has been obtained for the forecast and assessment on the antibodies market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The growth of end use industries in the historical and forecast period have been estimated to aid the readers with their business investment decisions. The market size of the antibodies is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.
Antibodies Market: Competitive Landscape
Major market players being instrumental for the growth of the antibodies market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis to provide a holistic picture of the competitive scenario of the antibodies market. A deep dive analysis of the major market players becomes indispensable as it will succor readers to make proper decision to enlarge their business and can comprehend strategic moves made by prominent players in the antibodies market.
The report has also profiled key players operating in the global antibodies market, which include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Genscript Biotech Corporation, Sigma Aldrich Corp, Crown Bioscience, Inc., Thermo Fisher Scientific, Inc.
Soaring incidence of chronic diseases such as cancer, diabetes and autoimmune conditions have acted as catalysts to drug makers to further augment antibody-based products. Consequently, research and development activities concerning antibodies has exponentially propped up in the past few decades. Meanwhile, the U.S. Food and Drug Administration (FDA) has given consent to more than a dozen mAbs to treat certain cancers. In addition, soaring acceptance of protein therapeutics along with ubiquity of epidemic diseases is having a sanguine impact on the sale of antibody-based products. However, one of the underlying problems is the prevalence of alternative therapeutics which does not augur well with the development of antibodies in global scale. Besides, high cost and side effects pertaining to antibodies further act as impediment to the sale of antibodies-based drug.
Currently, North America dominates the global antibodies market in terms of revenue and trend is projected continue in 2017 and beyond. In addition, the market in the region is expected to increase at a moderate CAGR during the forecast period (2017-2022). Presence of leading market players and existence of a well-established healthcare infrastructure is supporting the growth of the market in the region.
As B lymphocytes or B cells are pivotal in the production of antibodies, combined together they offer indispensable function of immunity. Offering a basis for the augmentation of therapeutic antibodies and for vaccine development turns out to be pivotal incentive for measuring antibody function.
Antibodies Market: Overview
The report moots a comprehensive analysis on the market for antibodies for the assessment period 2018-2026. The report also delves into the dynamics surrounding the antibodies which significantly influence the growth of the Antibodies Market.
Furthermore, the report elucidates the segregation of the market which is anticipated to provide readers with an actionable insights which will aid them in taking proper decision based on segments historical and future growth estimates.
Browse Full Report with ToC Here:
https://www.factmr.com/report/194/antibodies-market
The report focuses on cost structure and supply chain to provide a holistic view of the antibodies market. The report provides a coherent assessment through average pricing analysis. The report also includes regional and country-wise assessment.
A qualitative and quantitative information has been obtained for the forecast and assessment on the antibodies market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The growth of end use industries in the historical and forecast period have been estimated to aid the readers with their business investment decisions. The market size of the antibodies is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.
Antibodies Market: Competitive Landscape
Major market players being instrumental for the growth of the antibodies market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis to provide a holistic picture of the competitive scenario of the antibodies market. A deep dive analysis of the major market players becomes indispensable as it will succor readers to make proper decision to enlarge their business and can comprehend strategic moves made by prominent players in the antibodies market.
The report has also profiled key players operating in the global antibodies market, which include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Genscript Biotech Corporation, Sigma Aldrich Corp, Crown Bioscience, Inc., Thermo Fisher Scientific, Inc.
Comments
Post a Comment